A new patent dispute has exploded in the stem cell field related to induced pluripotent stem (iPS) cells. What’s going on? In 2006, Shinya Yamanaka reported cellular reprogramming to create mouse induced pluripotent stem (iPS) cells in Cell and the next year multiple groups along with Yamanaka’s reported creating human iPS cells. It’s no exaggeration […]
Challenge tries to cancel Yamanaka iPS cell patent Read More »
A team led by Shinya Yamanaka has published a new study reporting analysis of defective induced pluripotent stem (iPS) cells in the journal PNAS. Part of what I liked so much about this paper is that it tackled a very real, but controversial area of stem cell research. By this I mean the reality that a
Review of New Yamanaka Paper on Defective iPS cells Read More »
On November 15th the 2013 World Alliance Forum “Future of Stem Cells” will be held in San Francisco and Yamanaka will be there. It looks to be an awesome meeting. The lineup of speakers is frankly stunning and in part the meeting is to congratulate Shinya Yamanaka on winning the Nobel Prize. It is a once in a
Flash contest: win free ticket to see Yamanaka & friends in SFO Read More »
The Asahi Shimbun just published a fun, intriguing interview with Shinya Yamanaka, the Nobel Laureate who first produce iPS cells. In the interview, Yamanaka says that the celebrity aspect of his new post-Nobel life has driven him to wear disguises when out running in public because he gets recognized so often. Yamanaka is also asked
Great new Yamanaka interview on iPS cell safety, being a celebrity, & future plans Read More »
One of the big issues related to using induced pluripotent stem (iPS) cells is cost. To make iPS cells from each patient for subsequent stem cell-based treatment would cost a fortune, by some estimates $200,000 or more per patient if done one-by-one. It could easily end up not being covered by insurances companies and Medicare,
Yamanaka on making iPS cells from each patient: ‘in reality, we cannot do that’ Read More »
Did Dr. Hisashi Moriguchi really transplant iPS cells into human patients? The story has the stem cell field abuzz. My mind keeps changing on this one as earlier today I thought the whole thing maybe was a bunch of fluff, but now there is yet another new article (see headline below) in the Daily Yomiuri providing
I believe and have argued for years that Shinya Yamanaka, the discoverer of induced pluripotent stem cells (aka iPS cells) deserves the Nobel Prize. I’m very glad today that he received it. Some readers may find it a bit ironic that I believe so strongly in this way since over the years I have often
Why Yamanaka deserved the Nobel Prize for induced pluripotent stem cells Read More »
Stem cell revolutionaries Drs. Shinya Yamanaka and John Gurdon have won the 2012 Nobel Prize for Physiology or Medicine. Gurdon cloned for the first animal, a frog, and Yamanaka produced induced pluripotent stem cells (iPSCs), a kind of stem cell with the power of pluripotency, but derived from ordinary non-stem cells. Gurdon’s work was based
Nobel Prize 2012 for stem cells to Yamanaka & Gurdon: why only 2? Read More »
At the beginning of the year I wrote about a new kind of biotech called Altos Labs. It’s very different in some ways from other institutions. I find it an intriguing research entity. Where do things stand now with Altos Labs a few months later? More information, new ideas, and questions have popped up in the
Altos Labs: mission, leadership, jobs, & CIRM Read More »
When it comes to stem cells on Twitter and other social media, who do you follow now? Why them? Who are the top stem cell and regenerative medicine influencers to follow on Twitter and elsewhere in 2022? Stem cells on Twitter: great content amongst the noise Top stem cell and regenerative medicine influencers on Twitter.
50 influencers on stem cells on Twitter to follow in 2022 Read More »